Therapy of Steroid-Refractory Chronic GVHD with Subcutaneous Low-Dose Alemtuzumab and Rituximab Combination Is Effective and Safe

✍ Scribed by C.H. Gutierrez-Aguirre; O.G. Cantu-Rodriguez; O. Gonzalez-Llano; J.C. Jaime-Perez; C. Mancias-Guerra; J.A. Flores-Jimenez; J. Alatorre-Ricardo; D. Gomez-Almaguer

• Book ID: 116283242
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 47 KB
• Volume: 18
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2011.12.432